U.S. patent application number 11/982553 was filed with the patent office on 2008-06-26 for method for applying pulsed charge to living matter.
Invention is credited to Robert G. James.
Application Number | 20080154347 11/982553 |
Document ID | / |
Family ID | 37308422 |
Filed Date | 2008-06-26 |
United States Patent
Application |
20080154347 |
Kind Code |
A1 |
James; Robert G. |
June 26, 2008 |
Method for applying pulsed charge to living matter
Abstract
A treatment method for inducing electrically charged alignment
changes in biological tissue by placing a generally flat
translucent cavity containing a volume of gas that includes water
vapor, carbon dioxide and other similarly common molecules adjacent
the tissue and thereafter producing a charge at one surface of the
cavity by a sequence of pulses of electrical charge each of a
potential sufficient to excite the common molecules to a higher
state. A planar magnetic coil aligned generally parallel to the
plane of the cavity is then electrically excited by a second pulse
sequence to polarize the clockwise electromagnetic emissions
associated with the changes in the excitation states.
Inventors: |
James; Robert G.;
(Bakersfield, CA) |
Correspondence
Address: |
I. Michael Bak-Boychuk;Attorney at Law
P.O. Box 32501
Long Beach
CA
90832
US
|
Family ID: |
37308422 |
Appl. No.: |
11/982553 |
Filed: |
November 2, 2007 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
11117560 |
Apr 28, 2005 |
7302297 |
|
|
11982553 |
|
|
|
|
10798036 |
Mar 11, 2004 |
7130698 |
|
|
11117560 |
|
|
|
|
Current U.S.
Class: |
607/115 |
Current CPC
Class: |
H01J 65/046 20130101;
A61N 2005/065 20130101; A61N 2/02 20130101; H01J 61/12 20130101;
A61N 5/0613 20130101; A61N 2/002 20130101; A61N 1/40 20130101; A61N
2005/0655 20130101 |
Class at
Publication: |
607/115 |
International
Class: |
A61B 18/14 20060101
A61B018/14 |
Claims
1. A treatment method for inducing an increase in the charge state
of biological molecules included in living tissue, comprising:
producing an electrical charge across a generally planar,
rectangular hollow chamber defined by a front wall and an opposed
rear wall enclosing a volume of gas confined therebetween by
electrical excitation of a planar electrode affixed to the exterior
thereof in a contiguous alignment adjacent said rear wall;
periodically exciting an electrically conducting coil mounted on
the exterior periphery of said chamber aligned in a plane generally
parallel to said planar electrode to impose a uniformly aligned
field vector to said charge aligned substantially orthogonally to
said planar electrode; and aligning said chamber adjacent said
living tissue to direct said field vector into the interior thereof
to thereby induce emissions in said tissue in the hydrogen emission
band.
2. A treatment method according to claim 1, wherein: the step of
producing said electrical charge includes the further step of
cycling said electrical charge at a first preselected pulse
rate.
3. A treatment method according to claim 2, wherein: the step of
periodically exciting said electrically conducting coil includes
the further step of cycling said electrical excitation at a second
preselected pulse rate.
4. A treatment method according to claim 3, wherein: said first
preselected pulse rate is different than said second preselected
pulse rate.
5. A treatment method according to claim 1, wherein: said emissions
are at a wavelength substantially equal to 450 nanometers.
6. A treatment method according to claim 5, wherein: the step of
producing said electrical charge includes the further step of
cycling said electrical charge at a first preselected pulse rate;
and the step of periodically exciting said electrically conducting
coil includes the further step of cycling said electrical
excitation at a second preselected pulse rate.
7. A treatment method according to claim 6, wherein: said first and
second preselected pulse rates are maintained concurrently with the
step of aligning said chamber for a period generally equal to
twenty minutes.
8. A treatment method according to claim 1, wherein: the step of
producing said electrical charge includes the further step of
connecting a first electrical pulse means connected to said
electrode for producing a sequence of first electrical pulses of an
electrical potential relative the ambient charge level sufficient
to excite selected ones of the molecules comprising said volume of
gas to a higher level of excitation, each said occurrence of energy
change producing a discrete electromagnetic emission; and the step
of periodically exciting said electrically conducting coil includes
the further step of connecting second electrical pulse means to
said coil for producing a sequence of second electrical pulses
conducted through said coil to periodically generate a magnetic
flux field along a vector generally orthogonal to the plane of said
coil.
9. A treatment according to claim 8, wherein: said first pulse
sequence is at a different sequential rate than said second pulse
sequence.
10. A treatment method according to claim 9, wherein: said first
and second pulse sequences are maintained concurrently with the
step of aligning said chamber for a period generally equal or
greater than twenty minutes.
11. A treatment method according to claim 10, wherein: said
emissions are at a wavelength substantially equal to 450
nanometers.
Description
REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of U.S. patent
application Ser. No. 11/117,560 filed Apr. 28, 2005, which, in turn
is a continuation in part of U.S. patent application Ser. No.
10/798,036 filed 11 Mar., 2004, and benefit of these earlier filing
date is claimed for all matter common therewith.
BACKGROUND OF THE INVENTION
[0002] 1. The Technical Field
[0003] The present invention relates to pulsed charge devices, and
more particularly to charged surfaces coupled to anatomical parts
polarized to a right hand clockwise spin by a pulsed
electromagnetic field to induce electron state changes in the
biological matter.
[0004] 2. The Prior Art
[0005] In my prior U.S. Pat. No. 6,328,760 issued on Dec. 11, 2001
I have described a plasma device conformed to ionize certain
prevalent biological elements and molecules with the emission
spectra of this ionization process then coupling efficiently with
the dominant element and molecular structures in living matter. In
consequence, repair and reconstruction of living cells is both
accelerated and enhanced by the illumination with these selected
spectra. Since that time I have discovered that a fully developed
ionization process need not be utilized and an electrical potential
between the living matter and the charge sufficient to change some
of the electron states of the molecular combinations of living
tissue may produce the necessary molecular lattice rearrangement to
promote growth or healing.
[0006] Earlier I and others have observed that virtually all living
functions entail electrical potential balances and the cell itself
closely mimics a `wet circuit`. Sporadic disruptions of these
potential balances, either because of the introduction of some
contaminant or as result of some unwanted change in the charge
architecture, seem to be the causative events that lead to disease
and it is the rearrangement of this charge architecture anomalies
that appear to be at the heart of the process that I earlier
described in the '760 U.S. patent.
[0007] Of course, excepting those abnormalities that reach into the
genome itself most of these electro-potential effects seem to be at
the larger or macro level, such as those affecting the Na+/K+pump,
and the excitation of just some of the more basic molecules appears
to be sufficient to assist in rearranging the other charge
architectures back to their normal states.
[0008] The foregoing effect appears to have some confirmation in
scientific literature. For example, Horwitz, L R, Burke, T J,
Carnegie, D, 1999. Augmentation of Wound Healing Using
Monochromatic Infrared Energy; Exploration of a New Technology for
Wound Management. Advances in Wound Care 12:35-40 describes the use
of 890 nanometer monochromatic light effectively treating
recalcitrant dermal lesions and ulcers that sometimes resisted
conventional care for more than 39 years. Similarly, living tissue
molecular array response to weak electric and magnetic fields has
long been recognized. See, e.g., Adey, W R, Bawin, S M Brain
Interactions with Weak Electric and Magnetic Fields. Neurosciences
Research Program Bulletin 15(1):1-129. These and other publications
clearly establish an interactive relationship between living tissue
and weak electromagnetic fields.
[0009] Notably, however, this same effect is also associated with
emission of light in unique and distinct spectral patterns with a
symmetrical result then obtained by absorption of the light energy
in similar molecular structures illuminated thereby. In the bulk
tissue structure this interchange is polarity dependent obtainable
in an electromagnetic right hand spin polarizing field which may be
overlayed over the emitting source. Accordingly, a mechanism for
conveniently producing such right hand spin polarized emission
fields that induce response in living tissue including electron
state changes is extensively desired and it one such mechanism that
is disclosed herein.
SUMMARY OF THE INVENTION
[0010] Accordingly, it is the general purpose and object of the
present invention to provide a pulsed charge field contained in an
electromagnetic field conformed for raising the excitation states
of molecular bonding in biological molecules.
[0011] Other objects of the invention are to provide a pulsed
charge field including frequency spectra in each pulse within the
frequency domain of a wet circuit.
[0012] Yet further objects of the invention are to provide a pulsed
charge circuit completed through the charge architecture of living
matter.
[0013] Further objects of the invention are to provide a
conveniently implemented electrical charge field in circuit with
the wet circuit charge architecture of living matter.
[0014] Yet additional objects of the invention are to provide a
right hand spin polarizing electromagnetic field superposed onto a
charge field conformed to raise the excitation state of biological
matter.
[0015] Briefly, these and other objects are accomplished within the
present invention by providing a direct current powered oscillator
circuit transformer coupled to a plurality of voltage doubler
stages connected to the positive charge terminal that is shaped in
the form of a flat plate. The plate, in turn, is enclosed on the
exterior surface of a generally flat gas filled chamber that can be
pressed to the selected limb or body area of a person with the
local charge differential across the chamber then providing
localized electrical potentials which effect an energy state change
in the gas along with the associated radiation. By selecting a
molecular structure of the gas similar to the molecular structures
in the adjacent tissue a part of the emitted radiation is then
absorbed in the adjacent molecular arrays of the body, raising the
excitation levels in the tissue which propagate until a local
equilibrium is reached. This equilibrium includes the ambient
setting through which the ground return part of the circuit is
completed, with the lack of observable radiation then providing an
indication that the circuit impedance may be too high, i.e., that
the contact skin area may be too dry. In this manner the polar
molecules that are associated with all living tissue are included
in the circuit lattice responding both to the electrical potential
and to the gas emitted radiation.
[0016] The radiated emissions thus produced can then be further
controlled by a superimposed electromagnetic field produced on the
interior of a coil surrounding the flat negatively charged plate
and the chamber on which it is fixed. A further pulse circuit may
then be connected across the coil, thus exciting the
electromagnetic field to its selected pulse frequency. As result
the emissions in the chamber are uniformly right hand spin
polarized along their vectors that coincide with the field vector
within the coil, thus insuring a relatively uniform absorption
within the generally polar architecture of the molecular lattice
that forms the irradiated tissue.
[0017] Those skilled in the art will appreciate that virtually all
organic molecules are associated with a distributed electrical
charge. Very frequently it is this charge distribution that
determines the lobes and foldings of the larger molecules like
proteins or peptides and it is the occasional distortions in this
charge determined geometry that is often the suspected causative
agent associated with disease. Simply, the lobe architecture of a
large molecule may be altered by external effects which then alters
the molecular interactions with, e.g., receptors, until rearranged
to equilibrium state. Of course, the disease consequence associated
with distortions in our largest molecules, the chromosomes, are
well appreciated at this time and fundamental reasoning dictates
that the adjacent smaller molecules will invariably have some
effect across the whole range of molecular sizes. It is this effect
that is conveniently allowed to resolve itself by the inventive
structure disclosed herein.
BRIEF DESCRIPTION OF THE DRAWINGS
[0018] FIG. 1 is a perspective illustration of a prior art gas
discharge device useful in emitting light in biologically
significant spectra;
[0019] FIG. 2 is a perspective illustration, in partial sections,
of the inventive system illustrating the positioning thereof
adjacent a selected portion of a user's anatomy;
[0020] FIG. 3 is an exemplary electro-potential lattice
approximating the polar nature of human tissue that is exposed both
to a charged field and to light stimulation;
[0021] FIG. 4 is a circuit diagram of a pulsed charge circuit
useful with the present invention;
[0022] FIG. 5 is a diagrammatic illustration of the pulse shapes
provided by the circuit shown in FIG. 4;
[0023] FIG. 6 is a perspective illustration, in partial section, of
one physical configuration of the inventive pulse charge system
conformed as a manual applicator of a geometry that provides the
dominant discharge path across the charged cavity;
[0024] FIG. 7 is yet a further perspective illustration depicting
an electrically pulsed coil deployed in a surrounding alignment
about the charged electrode of the device shown in FIGS. 2 through
6 for developing a right hand spin polarizing electromagnetic field
useful in aligning the vectors of the emissions associated with the
change in the electron states effected by the electrical
charge;
[0025] FIG. 8 is a diagrammatic illustration of the combined
effects at the inventive intersection of the charge field within
the electromagnetic to polarize the light energy emitted in the
course of the electron state change along a common vector
exemplified in an alignment useful in treating macular
degeneration;
[0026] FIG. 9 is a further circuit diagram of a pulse circuit
useful in developing the electromagnetic field;
[0027] FIGS. 10a and 10b are further perspective illustrations of
exemplary holding structures for aligning the inventive charge
system adjacent selected portions of human anatomy; and
[0028] FIG. 11 is a graphical illustration of the spectral
distributions of the electromagnetic wavelength spectra emitted in
the course of use of the instant invention.
DESCRIPTION OF THE PREFERRED EMBODIMENT
[0029] By reference to FIG. 1 my prior U.S. Pat. No. 6,328,760
teaches a pulsed plasma radiation tube RT excited by a pulse
circuit PC to ionization potential of the gases contained therein
selected to emit radiation RA in biologically significant spectra
onto the treated body area BA of a user. To achieve this radiation
the gas within the plasma tube RT included molecules like water
vapor or H2O, carbon dioxide CO2, molecular nitrogen N2 and perhaps
carbonic acid H2CO3 all driven to ionization by the pulse circuit
PC. The resulting radiated spectra were then useful in exciting
illuminated tissue containing corresponding molecules, or loosely
bound components of larger molecules like peptides or proteins, and
the higher energy states of these excited elements and molecules
would induce, in the manner of a cascade, further state changes
propagated through the wet circuit of a cell. In this propagation
process any molecular distortions or electrical charge
misalignments would be freed up to return to their preferred state.
These molecular rearrangement by this negatively ionized gas
spectral illumination process have resulted in substantial
molecular responses, both useful in promoting healing and in the
maintenance of proper homeostasis.
[0030] While suitable for the purposes intended and widely useful
in the care of various diseases I have since found that the higher
potentials of full ionization are not necessary and, in stead, only
a sufficient charge difference to obtain an electron state response
need be applied. Although not fully understood, it appears that the
lattice of polar molecules that are included in all living tissue
provides its own charge distributions at the body surface and this
distribution may be used to advantage in producing sufficient
electric potential to effect an electron state change. Of course,
this is associated with a release of radiation which then raises
the state of other electrons and this state change then cascades
down into the treated tissue through its molecular lattice until
all the available state changes can be effected, and so on. In this
manner large body areas can be influenced with relatively low
electric potentials.
[0031] This lower level of charge differential can be conveniently
effected by modifying the pulse circuit of my earlier U.S. Pat. No.
6,328,760 and the teachings thereof are incorporated herein. By
reference to FIGS. 2 through 5 and by further reference to the
teachings of my prior '760 patent, like numbered parts functioning
in the like manner to that previously described, the inventive
system generally designated by the numeral 110 includes a generally
rectangular gas impervious chamber 120 defined by a flat
transparent front panel 121 peripherally bonded to the edges of a
mating concave rear panel 122 to form a closed cavity 123
therebetween. A conductor 125 is then extended along the exterior
of the rear panel 122 deploying a flat sheet electrode 126 over
chamber 120 under a sealing membrane 124 adhered to the edges of
rear panel 122.
[0032] Similar to the teachings of my prior '760 patent chamber 120
may be filled with a gaseous mixture of common molecules like water
vapor, carbon dioxide, carbonic acid and the like, each readily
brought to a higher excitation state by electrical charge of
electrode 126. To develop this charge potential the other end of
conductor 125, in turn, connects to a pulsed power source generally
designated 140 comprising a pulse stage 60 of similar construction
to that shown by the same numeral in my prior '760 patent, gated by
a voltage controlled oscillator 61 set in its oscillation frequency
by a potentiometer 62 in a voltage divider circuit between the
positive signal E- and ground. The output of oscillator 61 drives
to saturation at both limits of an operational amplifier 63 which
is then amplified by a power amplifier 65 that is tied to the
primary of a transformer 45 the secondary thereof driving a voltage
multiplier 150 comprising a lattice of diodes 51-1 through 51-m
interconnected by capacitors 52 with the last doubler stage at
diode 51-m then connecting to the conductor 125.
[0033] In accordance with the present invention the pulse potential
EF of conductor 125 is well below the ionization level of the gases
in cavity 123 but is sufficient to exceed the bonding potential of
the typical outer electrons of organic molecules, e.g., voltages
less than 50 volts. Thus only singular electromagnetic wavelengths
A associated with electron state change are emitted, particularly
those containing the spectra of the common molecular states.
[0034] It will be appreciated by those skilled in the art that the
foregoing pulse circuit is configured substantially like the pulse
circuit in the '760 patent. By reducing the number of
multiplication stages, however, the effective potential is
substantially below that resulting in ionizing disassociation and
the effect is primarily one of electric potential or charge. By
particular reference to FIG. 3 this charge effect couples with the
polar molecules like water WA-1 through WA-r, other polar organic
molecules like peptides PE-1 through PE-s, proteins PR-1 through
PR-t and so on. In the presence of an electric charge field these
will arrange in lattices or arrays AR where the polar difference
across this molecular array in the tissue and the molecular lattice
of the gas within cavity 123 is less than the potential EF at the
electrode 126. The excess electrode potential is then useful to
effect an electron state change along with the associated shedding
of light that may then cascade to excite corresponding molecules
WA-1 through WA-r in the tissue structure.
[0035] Those skilled in the art will appreciate that the foregoing
inventive system includes inherent discharge preferences that seek
out the shortest discharge paths. To confine these discharge
effects to a path across chamber 120, and preferably not across the
conductor 125 to ground, an applicator structure is illustrated in
FIG. 6 under the generally numbered designation 210 in which like
numbered parts function in like manner to those previously
described.
[0036] More precisely, applicator 210 is characterized by a
generally cylindrical handle 211 of a substantial radial and
longitudinal dimension and a dielectric material selected to
insulate the pulsed power source 140 including all the operative
components thereof. An electrical lead 212 then extends into handle
211 to provide the power signal E+ to circuit 140 which then
generates the sequence of pulses on the output conductor 125 and
the rectangular sheet electrode 126. Chamber 120 is formed on the
interior of an offset rectangular piece 221 extending in cantilever
from handle 211 with the electrode 126 mounted on the rear surface
222 thereof and thereafter sealed by an exterior membrane 224 in
this deployment. The front surface 223 of piece 221 can then be
manipulated into any desired contact alignment with the skin SK of
the user.
[0037] By selecting the material dielectric coefficients and
geometric spacing dimensions this structure insures that the
minimal discharge path is across chamber 120, thus insuring that
the user's hand UH does not by-pass the desired effect. In this
manner the primary result is the one previously described, a result
that assists in realigning the various molecular lobe structures of
the biological molecules affected.
[0038] I have further found that the foregoing effect can be
greatly enhanced by concurrently polarizing the common vectors of
each of the emitted light energy in cascade into an alignment along
with the charge field vector. To provide this right hand spin
polarization an electromagnetic field is developed in accordance
with the illustrations in FIGS. 7-9, wherein like numbered parts
function in like manner to that previously descry described.
[0039] More precisely, a coil 161 is wound around the interior
periphery of chamber 120 in a plane generally parallel to the plane
of the sheet electrode 126 in either one of the two applicator
forms 10 and 210, with the ends 162 and 163 of the coil then
connected across yet another pulse circuit 160 exemplified by the
implementation shown in FIG. 9, wherein an oscillator circuit is
formed by cross coupling the collector to base connections between
two transistors 181 and 182 with the base bias of transistor 182
controlled by a potentiometer 183 which, in combination with the
other resistors R1, R2 through Rs and capacitors C1 and C2, set the
desired oscillation frequency. The collector of transistor 182 then
drives the base of a transistor 184 in a switching circuit formed
by gating a transistor 185 in and out of conduction in a circuit
connection between the coil end 163 and ground, with the other end
162 of coil winding 161 connected to the power source E+. In this
manner a generally square wave pulse sequence is developed across
the coil, producing an electromagnetic field vector EMF aligned
generally orthogonally to the plane of the sheet electrode 126 and
cavity 120 and coinciding with the emitted radiation field vector
EF.
[0040] By particular reference to FIG. 8, the electromagnetic field
vector EMF imposes a corresponding uniformly aligned right hand
spin to the spectra A emitted by the constituent elements like O,
C, H and N both within chamber 120 and also in the adjacent tissue,
shown symbolically as the electromagnetic wavelengths right hand
spin vectors AS1 through ASm. By well known principles of physics
this coherent realignment of the spin vectors is obtainable without
any energy exchange, thus promoting a generally uniform, polarized
cascade through the tissue array AR in the course of their emission
and absorption that has little or no collateral energy exchange
associated therewith. I have found that electromagnetic field
levels as low as 0.7 Gauss are sufficient for effective penetration
of the field EMF through the adjacent tissue.
[0041] Thus the major risks associated with high energy irradiation
are minimized by limiting both the magnetic flux and the relative
electric potential of the electrode 120 to 50 volts. In this manner
irradiation of sensitive biological elements, like those in the
human eye, is rendered safe allowing for the charge realignments
and correction of all-trans retinal molecules, peptides, proteins
and chromosomes.
[0042] The usefulness of this irradiation process has had received
extensive verification in the course of Phase Two clinical trials
recently conducted to verify the therapeutic efficacy of the
inventive device in treating Age-Related Macular Degeneration
[AMD], Diabetic Retinopathy and Retinitis Pigmentosa, all retinal
diseases with few known treatment modalities. Periodic irradiation
of the retina of AMD patients, for example, directly through the
eye lens, in 20 minute intervals, has shown measurable improvement
in visual acuity as measured by the Vector Vision LogMar
instrumentation with one improvement as high as 57% and an
improvement average of 16%. Even higher treatment averages were
obtainable with a patient population that was limited to
early-stage AMD, with visual acuity improvement averages as high as
33%.
[0043] By reference to FIGS. 10a and 10b this irradiation treatment
of the retina can be rendered convenient by a holding structure
generally designated by the numeral 310, comprising a generally
circular strap 311 provided with overlapping ends 312 and 313
engageable to each other by opposing hook and pile segments, like
those sold under the mark "VELCRO", respectively shown as end
segments 312h and 313p, to form a hoop of various peripheral
dimensions. A holding bracket 315 may then be selectively clipped
to the strap 311 by interlaced engagement thereof between offset
tines 316 extending therefrom to deploy the applicator structure
210 over and adjacent to the anatomical area that is to be
irradiated.
[0044] As exemplified in FIGS. 8 and 10a strap 311 is positioned
about the circumference of a head of a patient with the holding
bracket 315 then clipped to the strap 311 over the forehead to
extend over the patient eyes EY with the irradiation then focused
by the eye lens EL onto the retina ER. With this assistance the
applicator structure 210 can be conveniently held right over the
eyes for the necessary durations determined by any treatment
regimen. Alternatively, as illustrated in FIG. 10b the bracket is
clipped to the strap 311 in alignment over the anterior surfaces of
the skull SA containing the visual cortex.
[0045] It is believed that by way of this polarized irradiation
small biological structures like the walls of the 0.8 micron
diameter capillary bed of the retinal macula RM are charged to an
equal polarity, thus promoting wall separation for an increased
flow. In consequence, circulation for nourishment and removal of
by-products is re-established, resolving the principal source for
the pathology of macular degeneration. I have further observed that
this process is rendered particularly effective in the spectral
emission and re-absorption of hydrogen in the 450 nanometer
emission band, suggesting the involvement of the hydrogen atom via
the All-trans-Retinal in the cones of the macula RM. This is
consistent with the generally observed deterioration with age in
the retinal perception of the blue color, now regenerated by this
inventive process, thereby restoring the fill visual range from the
ultraviolet to the infrared. Of course, similar benefits should
follow in other biological structures.
[0046] By this simple expedient the device can be variously
deployed over the body of the patient, resolving most degenerative
molecular malformations in the targeted tissue. Of course, other
shapes of the applicator structure 210 may be devised with
particular attention to the body shape that is intended for
exposure, such as cavities convolved into toroidal shapes to
surround a digit or limb or similar adaptations. In each instance,
however, the geometric constraint that needs to be met is one that
assures that the minimal discharge path is across the cavity.
[0047] By reference to FIG. 11 the spectral distribution of the
emissions from chamber 120 has been confirmed by actual measurement
including the several spectral peaks SP1-SPq associated with
biological matter and also the very pronounced hydrogen emission
spectrum peak HSP at 450 nanometer emission band referenced above.
Thus the theoretically inferred results are directly confirmed by
measurement which has been thereafter further confirmed by clinical
trials. Thus a conveniently deployed, relatively safe treatment
mechanism is devised which is broadly useful in realigning the
molecular architecture, and therefore the local charges, of living
matter
[0048] Obviously, many modifications and variations can be effected
without departing from the spirit of the invention instantly
disclosed. It is therefore intended that the scope of the invention
be determined solely by the claims appended hereto.
* * * * *